{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:50:03Z","timestamp":1790675403042,"version":"4.1.0"},"reference-count":347,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AA026609"],"award-info":[{"award-number":["R01AA026609"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.neuropharm.2022.109376","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T09:33:30Z","timestamp":1670751210000},"page":"109376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8777-302X","authenticated-orcid":false,"given":"Elyssa B.","family":"Margolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn G.","family":"Moulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Lambeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"O'Meara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109376_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0006-8993(02)02242-4","article-title":"Mu and delta opioid receptor-like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of pre- and postsynaptic receptor distributions","volume":"930","author":"Abbadie","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib2","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1038\/s41386-021-01168-2","article-title":"Release of endogenous dynorphin opioids in the prefrontal cortex disrupts cognition","volume":"46","author":"Abraham","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/903172","article-title":"Effectiveness of naltrexone in the prevention of delayed respiratory arrest in opioid-naive methadone-intoxicated patients","volume":"2013","author":"Aghabiklooei","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2022.109376_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/med.2610150104","article-title":"Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology","volume":"15","author":"Agnati","year":"1995","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2022.109376_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0006-8993(03)02678-7","article-title":"Endomorphin-2 axon terminals contact mu-opioid receptor-containing dendrites in trigeminal dorsal horn","volume":"977","author":"Aicher","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.ne.07.030184.001255","article-title":"Endogenous opioids: biology and function","volume":"7","author":"Akil","year":"1984","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neuron.2015.08.019","article-title":"Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward","volume":"87","author":"Al-Hasani","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109376_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(01)01014-7","article-title":"Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy","volume":"421","author":"Al-Khrasani","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s13318-018-0482-x","article-title":"Effect of naltrexone hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 activity in human liver microsomes","volume":"43","author":"AlRabiah","year":"2018","journal-title":"Eur. J. Drug Metab. Pharmokinet."},{"key":"10.1016\/j.neuropharm.2022.109376_bib10","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1530-0277.2011.01535.x","article-title":"Interaction between family history of alcoholism and locus of control in the opioid regulation of impulsive responding under the influence of alcohol","volume":"35","author":"Altamirano","year":"2011","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/cne.902950302","article-title":"Extensive co\u2010occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization","volume":"295","author":"Anderson","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/acer.13406","article-title":"Role of the dynorphin\/kappa opioid receptor system in the motivational effects of ethanol","volume":"41","author":"Anderson","year":"2017","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fncel.2016.00045","article-title":"Stress-induced enhancement of ethanol intake in C57bl\/6J mice with a history of chronic ethanol exposure: involvement of kappa opioid receptors","volume":"10","author":"Anderson","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","article-title":"An evaluation of \u03bc-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study","volume":"65","author":"Anton","year":"2008","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0741-8329(95)00038-0","article-title":"Plasma concentrations of \u03b2-endorphin, adrenocorticotropic hormone, and cortisol in drinking and abstinent chronic alcoholics","volume":"12","author":"Arbol","year":"1995","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2022.109376_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.tins.2014.07.010","article-title":"Presynaptic long-term depression mediated by Gi\/o-coupled receptors","volume":"37","author":"Atwood","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib17","article-title":"Nocistatin sensitizes TRPA1 channels in peripheral sensory neurons","volume":"11","author":"Avenali","year":"2016","journal-title":"Channels"},{"key":"10.1016\/j.neuropharm.2022.109376_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108131","article-title":"Endogenous opioid peptides in the descending pain modulatory circuit","volume":"173","author":"Bagley","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00213-005-2238-y","article-title":"Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice","volume":"181","author":"Balerio","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/01.ALC.0000075548.83053.A9","article-title":"A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence","volume":"27","author":"Balldin","year":"2003","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchemneu.2015.12.016","article-title":"Multiplexed neurochemical signaling by neurons of the ventral tegmental area","volume":"73","author":"Barker","year":"2016","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2022.109376_bib22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0306-4522(88)90184-4","article-title":"Endopeptidase-24.11 is striosomally ordered in pig brain and, in contrast to aminopeptidase n and peptidyl dipeptidase a (\u2018angiotensin converting enzyme\u2019), is a marker for a set of striatal efferent fibres","volume":"27","author":"Barnes","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109376_bib23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0306-4522(93)90490-7","article-title":"An immunoelectron microscopic study of pig substantia nigra shows co-localization of endopeptidase-24.11 with substance P","volume":"53","author":"Barnes","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109376_bib24","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/j.1471-4159.1992.tb10950.x","article-title":"Membrane localization of endopeptidase\u201024.11 and peptidyl dipeptidase A (angiotensin converting enzyme) in the pig brain: a study using subcellular fractionation and electron microscopic immunocytochemistry","volume":"58","author":"Barnes","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0304-3940(88)90271-6","article-title":"Electronmicroscopic immunocytochemistry of pig brain shows that endopeptidase-24.11 is localized in neuronal membranes","volume":"94","author":"Barnes","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109376_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1530-0277.2008.00633.x","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist?","volume":"32","author":"Baros","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.715215","article-title":"Decoding partner specificity of opioid receptor family","volume":"8","author":"Barreto","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1515\/BC.2007.039","article-title":"Human dipeptidyl peptidase III acts as a post-proline-cleaving enzyme on endomorphins","volume":"388","author":"Bar\u0161un","year":"2007","journal-title":"Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79418","article-title":"Whole-brain comparison of rodent and human brains using spatial transcriptomics","volume":"11","author":"Beauchamp","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2022.109376_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41386-018-0125-6","article-title":"Sex differences in neural mechanisms mediating reward and addiction","volume":"44","author":"Becker","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.mp.4000331","article-title":"\u03bc opioid receptor gene variants: lack of association with alcohol dependence","volume":"2","author":"Bergen","year":"1997","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0896-6273(00)80521-8","article-title":"CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-core vesicle exocytosis","volume":"21","author":"Berwin","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109376_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0014-2999(99)00245-9","article-title":"Ethanol-reinforced behaviour in the rat: effects of naltrexone","volume":"374","author":"Bienkowski","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41593-021-00854-0","article-title":"Functionally distinct POMC-expressing neuron subpopulations in hypothalamus revealed by intersectional targeting","volume":"24","author":"Biglari","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib35","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.biopsych.2014.08.021","article-title":"A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice","volume":"77","author":"Bilbao","year":"2015","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib36","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0021-9258(18)91389-X","article-title":"Isolation and properties of a new, biologically active peptide from sheep pituitary glands","volume":"239","author":"Birk","year":"1964","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib37","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1046\/j.1460-9568.1998.00190.x","article-title":"Enkephalin\u2010containing interneurons are specialized to innervate other interneurons in the hippocampal CA1 region of the rat and Guinea\u2010pig","volume":"10","author":"Blasco-Ib\u00e1\u00f1ez","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00235160","article-title":"Neurons of the rat hypothalamus reactive with antisera against endorphins, ACTH, MSH and \u03b2-LPH","volume":"204","author":"Bloch","year":"1979","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib39","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1073\/pnas.75.3.1591","article-title":"Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies","volume":"75","author":"Bloom","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cne.903630307","article-title":"Morphologically heterogeneous met\u2010enkephalin terminals form synapses with tyrosine hydroxylase\u2010containing dendrites in the rat nucleus locus coeruleus","volume":"363","author":"Bockstaele","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1096-9861(19961202)376:1<65::AID-CNE4>3.0.CO;2-M","article-title":"Mu\u2010opioid receptor is located on the plasma membrane of dendrites that receive asymmetric synapses from axon terminals containing leucine\u2010enkephalin in the rat nucleus locus coeruleus","volume":"376","author":"Bockstaele","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/(SICI)1096-9861(19971201)388:4<575::AID-CNE6>3.0.CO;2-#","article-title":"\u03b4\u2010opioid receptor is present in presynaptic axon terminals in the rat nucleus locus coeruleus: relationships with methionine5\u2010enkephalin","volume":"388","author":"van Bockstaele","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ng0893-332","article-title":"dbEST \u2014 database for \u201cexpressed sequence tags","volume":"4","author":"Boguski","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2022.109376_bib44","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters \u03b2-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib45","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.1073\/pnas.1919323117","article-title":"Mechanism and site of action of big dynorphin on ASIC1a","volume":"117","author":"Borg","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib46","article-title":"NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area","author":"Borruto","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib47","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41386-021-01096-1","article-title":"NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring rats","volume":"46","author":"Borruto","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0304-3959(00)00382-1","article-title":"Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration","volume":"90","author":"Boudinot","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2022.109376_bib50","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3565(25)24959-X","article-title":"Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord","volume":"238","author":"Bourgoin","year":"1986","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109376_bib51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1113\/jphysiol.2004.063818","article-title":"Autocrine feedback inhibition of plateau potentials terminates phasic bursts in magnocellular neurosecretory cells of the rat supraoptic nucleus","volume":"557","author":"Brown","year":"2004","journal-title":"J. Physiol. (London)"},{"key":"10.1016\/j.neuropharm.2022.109376_bib52","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1111\/j.0953-816X.2004.03408.x","article-title":"Phasic bursts in rat magnocellular neurosecretory cells are not intrinsically regenerative in vivo","volume":"19","author":"Brown","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib53","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fncel.2015.00196","article-title":"Advances in imaging ultrastructure yield new insights into presynaptic biology","volume":"9","author":"Bruckner","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib54","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/acer.14165","article-title":"NOP receptor antagonists decrease alcohol drinking in the dark in C57bl\/6J mice","volume":"43","author":"Brunori","year":"2019","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(96)00919-3","article-title":"Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids","volume":"321","author":"Butour","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/164_2021_433","article-title":"The kappa opioid receptor","volume":"271","author":"Cahill","year":"2021","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib57","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1021\/acschemneuro.8b00351","article-title":"Characterization of a multiple-scan-rate voltammetric waveform for real-time detection of met-enkephalin","volume":"10","author":"Calhoun","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib58","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuron.2019.03.003","article-title":"A motivational and neuropeptidergic hub: anatomical and functional diversity within the nucleus accumbens shell","volume":"102","author":"Castro","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109376_bib59","doi-asserted-by":"crossref","first-page":"T77","DOI":"10.1530\/JME-15-0323","article-title":"60 years of POMC: biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides","volume":"56","author":"Cawley","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1369-1600.2012.00442.x","article-title":"Association of \u03bc\u2010opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta\u2010analysis","volume":"17","author":"Chamorro","year":"2012","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib61","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the kappa opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109376_bib62","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1113\/jphysiol.1995.sp020541","article-title":"The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat","volume":"482","author":"Chen","year":"1995","journal-title":"J. Physiol. (London)"},{"key":"10.1016\/j.neuropharm.2022.109376_bib63","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1523\/JNEUROSCI.15-06-04602.1995","article-title":"The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin","volume":"15","author":"Chen","year":"1995","journal-title":"J Neurosci Official J Soc Neurosci"},{"key":"10.1016\/j.neuropharm.2022.109376_bib64","doi-asserted-by":"crossref","first-page":"RC168","DOI":"10.1523\/JNEUROSCI.21-19-j0003.2001","article-title":"Orexin (hypocretin) neurons contain dynorphin","volume":"21","author":"Chou","year":"2001","journal-title":"J Neurosci Official J Soc Neurosci"},{"key":"10.1016\/j.neuropharm.2022.109376_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00238213","article-title":"Striato-nigral dynorphin and substance P pathways in the rat","volume":"64","author":"Christensson-Nylander","year":"1986","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib66","first-page":"416","article-title":"Opioid use disorder: medical treatment options","volume":"100","author":"Coffa","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.neuropharm.2022.109376_bib67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/(SICI)1096-9861(19970512)381:3<373::AID-CNE8>3.0.CO;2-#","article-title":"Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus","volume":"381","author":"Commons","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib68","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn1455","article-title":"Anatomy and regulation of the central melanocortin system","volume":"8","author":"Cone","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib69","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/sj.bjp.0702971","article-title":"Nociceptin, Phe1\u03c8\u2010nociceptin1\u201313, nocistatin and prepronociceptin154\u2013181 effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro","volume":"128","author":"Connor","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2022.100016","article-title":"Challenges and new opportunities for detecting endogenous opioid peptides in reward","volume":"2","author":"Conway","year":"2022","journal-title":"Addict Neurosci"},{"key":"10.1016\/j.neuropharm.2022.109376_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-neuro-080317-061522","article-title":"Endogenous and exogenous opioids in pain","volume":"41","author":"Corder","year":"2018","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.reuma.2010.12.007","article-title":"Oxidative stress in Fibromyalgia: pathophysiology and clinical implications","volume":"7","author":"Cordero","year":"2011","journal-title":"Reumatolog\u00eda Cl\u00ednica Engl Ed"},{"key":"10.1016\/j.neuropharm.2022.109376_bib73","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0024-3205(82)90179-5","article-title":"Endogenous opioid peptides: a guide to structures and terminology","volume":"31","author":"Cox","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837671","article-title":"The kappa opioid receptor: a promising therapeutic target for multiple pathologies","volume":"13","author":"Dalefield","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbapap.2005.05.010","article-title":"Type 2 diabetes\u2014therapy with dipeptidyl peptidase IV inhibitors","volume":"1751","author":"Demuth","year":"2005","journal-title":"Biochimica Et Biophysica Acta Bba - Proteins Proteom"},{"key":"10.1016\/j.neuropharm.2022.109376_bib76","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.cub.2012.08.014","article-title":"Enkephalin surges in dorsal neostriatum as a signal to eat","volume":"22","author":"DiFeliceantonio","year":"2012","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib77","article-title":"Imaging neuropeptide release at synapses with a genetically engineered reporter","volume":"8","author":"Ding","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2022.109376_bib78","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1523\/JNEUROSCI.14-06-03736.1994","article-title":"Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters","volume":"14","author":"Drake","year":"1994","journal-title":"J Neurosci Official J Soc Neurosci"},{"key":"10.1016\/j.neuropharm.2022.109376_bib79","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0376-19.2020","article-title":"Differential modulation of ventral tegmental area circuits by the nociceptin\/orphanin FQ system","volume":"7","author":"Driscoll","year":"2020","journal-title":"Eneuro"},{"key":"10.1016\/j.neuropharm.2022.109376_bib80","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/acer.13896","article-title":"Meta\u2010analysis of genetic influences on initial alcohol sensitivity","volume":"42","author":"Edwards","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib81","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/13556210500314550","article-title":"Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?","volume":"10","author":"Egli","year":"2005","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.ne.15.030192.000421","article-title":"The biosynthesis of neuropeptides: peptide alpha-amidation","volume":"15","author":"Eipper","year":"1992","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib83","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/acer.13999","article-title":"Naltrexone acutely enhances connectivity between the ventromedial prefrontal cortex and a left frontoparietal network","volume":"43","author":"Elton","year":"2019","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib84","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2005.01.002","article-title":"The level of response to alcohol in daughters of alcoholics and controls","volume":"79","author":"Eng","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2022.109376_bib85","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neuropharm.2018.07.034","article-title":"Maladaptive behavioral regulation in alcohol dependence: role of kappa-opioid receptors in the bed nucleus of the stria terminalis","volume":"140","author":"Erikson","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib86","first-page":"e6287","article-title":"A retrospective study of hospital recidivism among patients with alcohol use disorders treated with intramuscular naltrexone","volume":"11","author":"Espiridion","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.neuropharm.2022.109376_bib87","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cne.902490302","article-title":"Distribution of dynorphin and enkephalin peptides in the rat brain","volume":"249","author":"Fallon","year":"1986","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib88","article-title":"Correction: CAPS-1 promotes fusion competence of stationary dense-core vesicles in presynaptic terminals of mammalian neurons","volume":"4","author":"Farina","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2022.109376_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/msb.2009.27","article-title":"Targeted tandem affinity purification of PSD\u201095 recovers core postsynaptic complexes and schizophrenia susceptibility proteins","volume":"5","author":"Fern\u00e1ndez","year":"2009","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib90","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1124\/pr.59.1.3","article-title":"The endomorphin system and its evolving neurophysiological role","volume":"59","author":"Fichna","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109376_bib91","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0092-8674(88)91131-2","article-title":"Multiple neuropeptides derived from a common precursor are differentially packaged and transported","volume":"54","author":"Fisher","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109376_bib92","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/S0024-3205(99)00541-X","article-title":"Comparison of behavioural effects of NocII or NocIII, two related pronociceptin-derived peptides","volume":"65","author":"Florin","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib93","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00001756-199702100-00025","article-title":"Orphan neuropeptide NocII, a putative pronociceptin maturation product, stimulates locomotion in mice","volume":"8","author":"Florin","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2022.109376_bib94","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1152\/jn.00963.2006","article-title":"Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents","volume":"97","author":"Ford","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib95","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0014-2999(84)90575-2","article-title":"Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes","volume":"102","author":"Fournie-Zaluski","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib96","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1096-8628(20010108)105:1<114::AID-AJMG1074>3.0.CO;2-L","article-title":"Nonreplication of association between \u03bc\u2010opioid\u2010receptor gene (OPRM1) A118G polymorphism and substance dependence","volume":"105","author":"Franke","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2022.109376_bib97","doi-asserted-by":"crossref","DOI":"10.1124\/mol.120.119388","article-title":"Five decades of research on opioid peptides: current knowledge and unanswered questions","volume":"98","author":"Fricker","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib98","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1523\/JNEUROSCI.3240-20.2021","article-title":"CAPS2 deficiency impairs the release of the social peptide oxytocin, as well as oxytocin-associated social behavior","volume":"41","author":"Fujima","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib99","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib100","article-title":"Reversal and prevention of the respiratory-depressant effects of heroin by the novel \u03bc opioid receptor antagonist methocinnamox in rhesus monkeys","volume":"368","author":"Gerak","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109376_bib101","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109376_bib102","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(88)91217-6","article-title":"Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study","volume":"460","author":"Gerfen","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib103","doi-asserted-by":"crossref","first-page":"12772","DOI":"10.1073\/pnas.96.22.12772","article-title":"Molecular cloning and functional analysis of SUT-1, a sulfate transporter from human high endothelial venules","volume":"96","author":"Girard","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2022.09.005","article-title":"Emerging approaches for decoding neuropeptide transmission","author":"Girven","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib105","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1073\/pnas.2000712117","article-title":"Biased signaling by endogenous opioid peptides","volume":"117","author":"Gomes","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib106","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1523\/JNEUROSCI.18-24-10663.1998","article-title":"Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens","volume":"18","author":"Gonzales","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib107","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0741-8329(01)00163-X","article-title":"Effects of naltrexone on the intake of ethanol and flavored solutions in rats","volume":"25","author":"Goodwin","year":"2001","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2022.109376_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2022.102576","article-title":"Nanoscale organization of the pre-synapse: tracking the neurotransmitter release machinery","volume":"75","author":"Gormal","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib109","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/gb-2003-4-9-117","article-title":"Comparing protein abundance and mRNA expression levels on a genomic scale","volume":"4","author":"Greenbaum","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib110","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/j.1530-0277.2010.01267.x","article-title":"Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study","volume":"34","author":"Greenfield","year":"2010","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib111","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/00952998109009554","article-title":"Naltrexone: a short-term treatment for opiate dependence","volume":"8","author":"Greenstein","year":"1981","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.neuropharm.2022.109376_bib112","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1745-7270.2008.00418.x","article-title":"How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes","volume":"40","author":"Guo","year":"2008","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.neuropharm.2022.109376_bib113","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1471-4159.2011.07361.x","article-title":"Potentiation of \u03bc\u2010opioid receptor\u2010mediated signaling by ketamine","volume":"119","author":"Gupta","year":"2011","journal-title":"J Neurochem, Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2022.109376_bib114","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10571-020-01015-w","article-title":"Regulation of opioid receptors by their endogenous opioid peptides","volume":"41","author":"Gupta","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajhg.2011.05.028","article-title":"Exome sequencing identifies CCDC8 mutations in 3-M syndrome, suggesting that CCDC8 contributes in a pathway with CUL7 and OBSL1 to control human growth","volume":"89","author":"Hanson","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2022.109376_bib116","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13073-017-0467-4","article-title":"A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications","volume":"9","author":"Haque","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.neuropharm.2022.109376_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.04.036","article-title":"Central amygdala prepronociceptin-expressing neurons mediate palatable food consumption and reward","author":"Hardaway","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109376_bib118","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/271677a0","article-title":"In vitro release of Leu- and Met-enkephalin from the corpus striatum","volume":"271","author":"Henderson","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109376_bib119","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1007\/s00213-014-3571-9","article-title":"Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats","volume":"231","author":"Henderson-Redmond","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib120","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/antiox9111166","article-title":"The interplay between oxidative stress, exercise, and pain in health and disease: potential role of autonomic regulation and epigenetic mechanisms","volume":"9","author":"Hendrix","year":"2020","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109376_bib348","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10550490590949488","article-title":"Treatment compliance in patients with comorbid psychiatric and substance use disorders","volume":"14","author":"Herbeck","year":"2005","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2022.109376_bib121","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1530-0277.2006.00101.x","article-title":"Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking","volume":"30","author":"Hernandez-Avila","year":"2006","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib122","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050169","article-title":"Endogenous opioid systems and alcohol addiction","volume":"129","author":"Herz","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib123","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41592-021-01316-y","article-title":"Spatial mapping of protein composition and tissue organization: a primer for multiplexed antibody-based imaging","volume":"19","author":"Hickey","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2022.109376_bib124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2009.03.012","article-title":"Opioid receptors in the gastrointestinal tract","volume":"155","author":"Holzer","year":"2009","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2022.109376_bib125","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1006\/bbrc.1996.0300","article-title":"Structure and regional distribution of nociceptin\/orphanin FQ precursor","volume":"219","author":"Houtani","year":"1996","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.neuropharm.2022.109376_bib126","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/258577a0","article-title":"Identification of two related pentapeptides from the brain with potent opiate agonist activity","volume":"258","author":"Hughes","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109376_bib127","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1111\/j.1742-4658.2005.04919.x","article-title":"Structural function of C\u2010terminal amidation of endomorphin","volume":"272","author":"In","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2022.109376_bib128","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1073\/pnas.75.12.6300","article-title":"alpha-Melanocyte stimulating hormone: immunohistochemical identification and mapping in neurons of rat brain","volume":"75","author":"Jacobowitz","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib129","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0024-3205(82)90374-5","article-title":"Selectivity of dynorphin for \u03ba opioid receptors","volume":"31","author":"James","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib130","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1530-0277.2009.00924.x","article-title":"Effect of acute ethanol administration on the release of opioid peptides from the midbrain including the ventral tegmental area","volume":"33","author":"Jarjour","year":"2009","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib131","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended\u2010release injectable naltrexone for opioid use disorder: a systematic review","volume":"113","author":"Jarvis","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2022.109376_bib132","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-5728(99)00216-7","article-title":"Novel opioid peptides endomorphin-1 and endomorphin-2 are present in mammalian immune tissues","volume":"106","author":"Jessop","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib133","doi-asserted-by":"crossref","first-page":"22672","DOI":"10.1074\/jbc.273.35.22672","article-title":"Specificity of prohormone convertase 2 on proenkephalin and proenkephalin-related substrates","volume":"273","author":"Johanning","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib134","first-page":"741","article-title":"Naltrexone long-acting formulation in the treatment of alcohol dependence","volume":"3","author":"Johnson","year":"2007","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.neuropharm.2022.109376_bib135","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib136","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0003-9861(80)90048-X","article-title":"Structure of two adrenal polypeptides containing multiple enkephalin sequences","volume":"204","author":"Jones","year":"1980","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2022.109376_bib137","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1034\/j.1399-3011.2003.00077.x","article-title":"N-terminal modifications leading to peptide ORL1 partial agonists and antagonists","volume":"62","author":"Judd","year":"2003","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib138","series-title":"Narcotic Antagonists: Naltrexone Progress Report 9, NIDA Research Monograph Series","year":"1976"},{"key":"10.1016\/j.neuropharm.2022.109376_bib139","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fnana.2018.00072","article-title":"Active zone material-directed orientation, docking, and fusion of dense core vesicles alongside synaptic vesicles at neuromuscular junctions","volume":"12","author":"Jung","year":"2018","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuropharm.2022.109376_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413619","article-title":"Non-opioid peptides targeting opioid effects","volume":"22","author":"Kaczy\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib141","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cell.2010.12.029","article-title":"RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction","volume":"144","author":"Kaeser","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109376_bib142","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2000017118","article-title":"Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects","volume":"118","author":"Kandasamy","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib143","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1021\/ar900175a","article-title":"Oxidation of DNA: damage to nucleobases","volume":"43","author":"Kanvah","year":"2010","journal-title":"Accounts Chem. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib144","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1152\/physrev.00007.2012","article-title":"Distinct initial SNARE configurations underlying the diversity of exocytosis","volume":"92","author":"Kasai","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109376_bib145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0006-8993(89)90974-8","article-title":"Potent antinociceptive effects of Kelatorphan (a highly efficient inhibitor of multiple enkephalin-degrading enzymes) systemically administered in normal and arthritic rats","volume":"497","author":"Kayser","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib146","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1530-0277.2011.01611.x","article-title":"Opioidergic modulation of ethanol self\u2010administration in the ventral pallidum","volume":"36","author":"Kemppainen","year":"2012","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114785","article-title":"A systematic review on the kappa opioid receptor and its ligands: new directions for the treatment of pain, anxiety, depression, and drug abuse","volume":"243","author":"Khan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib148","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s42003-022-03388-8","article-title":"Optimized single-step optical clearing solution for 3D volume imaging of biological structures","volume":"5","author":"Kim","year":"2022","journal-title":"Commun Biology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025864","article-title":"Relative number and distribution of murine hypothalamic proopiomelanocortin neurons innervating distinct target sites","volume":"6","author":"King","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.109376_bib150","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/npp.2015.183","article-title":"Dissociating motivational from physiological withdrawal in alcohol dependence: role of central amygdala \u03ba-opioid receptors","volume":"41","author":"Kissler","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib151","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0024-3205(78)90434-4","article-title":"Brain enkephalin distribution is unaltered by hypophysectomy","volume":"22","author":"Kobayashi","year":"1978","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib152","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jaci.2021.08.003","article-title":"Peripheral endomorphins drive mechanical alloknesis under the enzymatic control of CD26\/DPPIV","volume":"149","author":"Komiya","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib153","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/adb.12393","article-title":"Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors","volume":"22","author":"Korpi","year":"2017","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib154","first-page":"571","article-title":"Endogenous opioids and their receptors","volume":"39","author":"Kosterlitz","year":"1987","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.neuropharm.2022.109376_bib155","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and pharmacotherapy of alcohol use disorder: a review","volume":"320","author":"Kranzler","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib156","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41591-020-0806-7","article-title":"A randomized proof-of-mechanism trial applying the \u2018fast-fail\u2019 approach to evaluating \u03ba-opioid antagonism as a treatment for anhedonia","volume":"26","author":"Krystal","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2022.109376_bib157","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60270","article-title":"Compartment-specific opioid receptor signaling is selectively modulated by different Dynorphin peptides","volume":"10","author":"Kunselman","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2022.109376_bib158","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/nn.4068","article-title":"Coding the direct\/indirect pathways by D1 and D2 receptors is not valid for accumbens projections","volume":"18","author":"Kupchik","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib159","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.celrep.2018.02.010","article-title":"Munc13-3 is required for the developmental localization of Ca2+ channels to active zones and the nanopositioning of Cav2.1 near release sensors","volume":"22","author":"Kusch","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2022.109376_bib160","first-page":"571","article-title":"The neuropeptide nocistatin is not a direct agonist of acid-sensing ion channel 1a (ASIC1a)","volume":"11","author":"Kuspiel","year":"2021","journal-title":"Biomol"},{"key":"10.1016\/j.neuropharm.2022.109376_bib161","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.brainres.2009.05.067","article-title":"Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics","volume":"1305","author":"Kuzmin","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib162","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/sj.npp.1300959","article-title":"Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice","volume":"31","author":"Kuzmin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib163","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-009-1733-y","article-title":"Effects of acute ethanol on \u03b2-endorphin release in the nucleus accumbens of selectively bred lines of alcohol-preferring AA and alcohol-avoiding ANA rats","volume":"208","author":"Lam","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib164","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0014-5793(98)00452-9","article-title":"Different domains of the ORL1 and \u03ba\u2010opioid receptors are involved in recognition of nociceptin and dynorphin A","volume":"427","author":"Lapalu","year":"1998","journal-title":"Febs Lett"},{"key":"10.1016\/j.neuropharm.2022.109376_bib165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/bs.vh.2014.11.001","article-title":"Chapter three ancestral vertebrate complexity of the opioid system","volume":"97","author":"Larhammar","year":"2015","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.neuropharm.2022.109376_bib166","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ijporl.2011.07.037","article-title":"Activity of soluble aminopeptidase A and dipeptidyl peptidase IV and membrane-bound aminopeptidase B and pyroglutamyl peptidase I in adenoid hyperplasia, tonsillar hyperplasia and chronic tonsillitis","volume":"75","author":"Larrinaga","year":"2011","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib167","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0304-3940(90)90117-R","article-title":"Immunocytochemical localization of endopeptidase-24.11 in the nucleus tractus solitarius of the rat brain","volume":"117","author":"Lasher","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109376_bib168","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cne.902300409","article-title":"Immunoreactive pro\u2010enkephalin and pro\u2010dynorphin products are differentially distributed within the nucleus of the solitary tract of the rat","volume":"230","author":"Lee","year":"1984","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib169","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2022.109376_bib170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(97)13363-8","article-title":"Ultrastructural relationships of the pro-opiomelanocortin axons with the serotoninergic neurons in the dorsal raphe nucleus of the rat","volume":"222","author":"L\u00e9ger","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109376_bib171","doi-asserted-by":"crossref","first-page":"392","DOI":"10.9740\/mhc.2019.11.392","article-title":"Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans","volume":"9","author":"Leighty","year":"2019","journal-title":"Ment Heal Clin"},{"key":"10.1016\/j.neuropharm.2022.109376_bib172","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.neuron.2017.07.036","article-title":"Input-timing-dependent plasticity in the hippocampal CA2 region and its potential role in social memory","volume":"95","author":"Leroy","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109376_bib173","article-title":"Enkephalin release from VIP interneurons in the hippocampal CA2\/3a region mediates heterosynaptic plasticity and social memory","volume":"1\u201322","author":"Leroy","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib174","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(96)01126-X","article-title":"Multiple opioid receptor\u2010like genes are identified in diverse vertebrate phyla","volume":"397","author":"Li","year":"1996","journal-title":"Febs Lett"},{"key":"10.1016\/j.neuropharm.2022.109376_bib175","doi-asserted-by":"crossref","first-page":"eabj7360","DOI":"10.1126\/scitranslmed.abj7360","article-title":"Brain circuits for pain and its treatment","volume":"13","author":"Lindsay","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2022.109376_bib176","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jneumeth.2005.06.001","article-title":"A new electrochemical HPLC method for analysis of enkephalins and endomorphins","volume":"150","author":"Lisi","year":"2006","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2022.109376_bib177","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1523\/JNEUROSCI.0274-19.2019","article-title":"Kappa opioid receptors drive a tonic aversive component of chronic pain","volume":"39","author":"Liu","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib178","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/acschemneuro.7b00097","article-title":"MEL-N16: a series of novel endomorphin analogs with good analgesic activity and a favorable side effect profile","volume":"8","author":"Liu","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib179","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/289317a0","article-title":"Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells","volume":"289","author":"Livett","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109376_bib180","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/267495a0","article-title":"Endogenous opioid peptides: multiple agonists and receptors","volume":"267","author":"Lord","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109376_bib181","doi-asserted-by":"crossref","first-page":"541","DOI":"10.15585\/mmwr.mm7015a1","article-title":"State-level economic costs of opioid use disorder and fatal opioid overdose \u2014 United States, 2017","volume":"70","author":"Luo","year":"2021","journal-title":"Morbidity Mortal Wkly Rep"},{"key":"10.1016\/j.neuropharm.2022.109376_bib182","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1471-4159.2011.07293.x","article-title":"Microdialysis and mass spectrometric monitoring of dopamine and enkephalins in the globus pallidus reveal reciprocal interactions that regulate movement","volume":"118","author":"Mabrouk","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib183","article-title":"The emerging role of dipeptidyl peptidase 3 in pathophysiology","author":"Malovan","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2022.109376_bib184","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1586\/14737175.7.10.1265","article-title":"Long-acting injectable naltrexone for the treatment of alcohol dependence","volume":"7","author":"Mannelli","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2022.109376_bib185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(95)00928-J","article-title":"The cloned \u03bc, \u03b4 and \u03ba receptors and their endogenous ligands: evidence for two opioid peptide recognition cores","volume":"700","author":"Mansour","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib186","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0169-328X(97)00371-9","article-title":"Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain","volume":"55","author":"Manzanares","year":"1998","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib187","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cne.21464","article-title":"Coexpression of prodynorphin and corticotrophin\u2010releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division","volume":"504","author":"Marchant","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib188","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1523\/JNEUROSCI.4569-08.2008","article-title":"\u03b4-Opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption","volume":"28","author":"Margolis","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib189","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1523\/JNEUROSCI.23-31-09981.2003","article-title":"\u03ba-Opioid agonists directly inhibit midbrain dopaminergic neurons","volume":"23","author":"Margolis","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104504","article-title":"Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion","volume":"129","author":"Margolis","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2022.109376_bib191","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4037\/aacnacc2019931","article-title":"Assessing patients' risk for opioid use disorder","volume":"30","author":"Marie","year":"2019","journal-title":"AACN Adv. Crit. Care"},{"key":"10.1016\/j.neuropharm.2022.109376_bib192","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/01.alc.0000183008.62955.2e","article-title":"A microdialysis profile of met-enkephalin release in the rat nucleus accumbens following alcohol administration","volume":"29","author":"Marinelli","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib193","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1530-0277.2006.00112.x","article-title":"A microdialysis profile of dynorphin A1\u20138 release in the rat nucleus accumbens following alcohol administration","volume":"30","author":"Marinelli","year":"2006","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib194","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00213-003-1490-2","article-title":"A microdialysis profile of \u03b2-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration","volume":"169","author":"Marinelli","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib195","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109376_bib196","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/(SICI)1096-9861(19990322)405:4<450::AID-CNE2>3.0.CO;2-#","article-title":"Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent","volume":"405","author":"Martin-Schild","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib197","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0196-9781(97)00320-3","article-title":"Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord","volume":"18","author":"Martin-Schild","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2022.109376_bib198","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/cbic.201900317","article-title":"Biosynthetic short neuropeptides: a rational theory based on experimental results for the missing pain\u2010relief opioid endomorphin precursor gene","volume":"20","author":"Matsushima","year":"2019","journal-title":"Chembiochem"},{"key":"10.1016\/j.neuropharm.2022.109376_bib199","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/acer.13898","article-title":"Exploring sex differences in the attenuation of ethanol drinking by naltrexone in dependent rats during early and protracted abstinence","volume":"42","author":"Matzeu","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib200","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0306-4522(98)00514-4","article-title":"Activation and internalization of the \u03bc-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2\u2020\u2020These authors contributed equally to this work","volume":"90","author":"McConalogue","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109376_bib201","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00089-0","article-title":"Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides","volume":"85","author":"Mentlein","year":"1999","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2022.109376_bib202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1471-4159.2006.03732.x","article-title":"Big dynorphin as a putative endogenous ligand for the \u03ba\u2010opioid receptor","volume":"97","author":"Merg","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib203","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Merrer","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109376_bib204","doi-asserted-by":"crossref","first-page":"R982","DOI":"10.1152\/ajpregu.00169.2021","article-title":"Individual arcuate nucleus proopiomelanocortin neurons project to select target sites","volume":"321","author":"Metz","year":"2021","journal-title":"Am J Physiology-regulatory Integr Comp Physiology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib205","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1038\/s41598-019-43657-x","article-title":"Temporal dependence of shifts in mu opioid receptor mobility at the cell surface after agonist binding observed by single-particle tracking","volume":"9","author":"Metz","year":"2019","journal-title":"Sci Rep-uk"},{"key":"10.1016\/j.neuropharm.2022.109376_bib206","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109376_bib207","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1743-7075-4-18","article-title":"The role of proopiomelanocortin (POMC) neurones in feeding behaviour","volume":"4","author":"Millington","year":"2007","journal-title":"Nutr. Metabol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib208","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1254\/jphs.10003FP","article-title":"Analysis of the effects of anesthetics and ethanol on \u03bc-opioid receptor","volume":"112","author":"Minami","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib209","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub3","article-title":"Oral naltrexone maintenance treatment for opioid dependence","author":"Minozzi","year":"2011","journal-title":"Cochrane Db Syst Rev CD001333"},{"key":"10.1016\/j.neuropharm.2022.109376_bib210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nbd.2008.09.018","article-title":"Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol","volume":"33","author":"Mitchell","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109376_bib211","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00213-005-0067-7","article-title":"A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats","volume":"182","author":"Mitchell","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib212","doi-asserted-by":"crossref","first-page":"116ra6","DOI":"10.1126\/scitranslmed.3002902","article-title":"Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens","volume":"4","author":"Mitchell","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2022.109376_bib213","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.npp.1301226","article-title":"Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls","volume":"32","author":"Mitchell","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib214","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)80235-1","article-title":"ORL1, a novel member of the opioid receptor family","volume":"341","author":"Mollereau","year":"1994","journal-title":"Febs Lett"},{"key":"10.1016\/j.neuropharm.2022.109376_bib215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn.2016.165","article-title":"Ventral tegmental area: cellular heterogeneity, connectivity and behaviour","volume":"18","author":"Morales","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib216","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1523\/JNEUROSCI.03-03-00603.1983","article-title":"The peptidergic organization of the cat periaqueductal gray. I. The distribution of immunoreactive enkephalin-containing neurons and terminals","volume":"3","author":"Moss","year":"1983","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib217","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-8993(83)90004-5","article-title":"The fine structure of the caudal periaqueductal gray of the cat: morphology and synaptic organization of normal and immunoreactive enkephalin-labeled profiles","volume":"289","author":"Moss","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib218","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1073\/pnas.78.11.6623","article-title":"Purification of a membrane-bound metalloendopeptidase from porcine kidney that degrades peptide hormones","volume":"78","author":"Mumford","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib219","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neulet.2015.12.008","article-title":"Immunoelectron microscopic observation of the subcellular localization of kisspeptin, neurokinin B and dynorphin A in KNDy neurons in the arcuate nucleus of the female rat","volume":"612","author":"Murakawa","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109376_bib220","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.cell.2015.11.025","article-title":"Simple, scalable proteomic imaging for high-dimensional profiling of intact systems","volume":"163","author":"Murray","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109376_bib221","doi-asserted-by":"crossref","first-page":"E1648","DOI":"10.1073\/pnas.1315542111","article-title":"Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area","volume":"111","author":"Muschamp","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib222","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.npp.1300858","article-title":"Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala","volume":"31","author":"Narita","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib223","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0014-2999(98)00395-1","article-title":"Characterization of endomorphin-1 and -2 on [35S]GTP\u03b3S binding in the mouse spinal cord","volume":"351","author":"Narita","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib224","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cne.902880302","article-title":"Prodynorphin peptide distribution in the forebrain of the syrian hamster and rat: a comparative study with antisera against dynorphin A, dynorphin B, and the C\u2010terminus of the prodynorphin precursor molecule","volume":"288","author":"Neal","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib225","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/archpsyc.1978.01770270085008","article-title":"Clinical evaluation of naltrexone treatment of opiate-dependent individuals: report of the national research council committee on clinical evaluation of narcotic antagonists","volume":"35","year":"1978","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib226","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0741-8329(95)02038-1","article-title":"Naltrexone in the treatment of alcoholism: a clinical review","volume":"13","author":"O'Brien","year":"1996","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2022.109376_bib227","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/32660","article-title":"Nocistatin, a peptide that blocks nociceptin action in pain transmission","volume":"392","author":"Okuda-Ashitaka","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109376_bib228","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1152\/physiolgenomics.00224.2006","article-title":"Microarray analysis reveals distinctive signaling between the bed nucleus of the stria terminalis, nucleus accumbens, and dorsal striatum","volume":"32","author":"Olsen","year":"2008","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.neuropharm.2022.109376_bib229","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/jcp.0b013e31814ce50d","article-title":"Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment","volume":"27","author":"O'Malley","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.1996.01830030039007","article-title":"Six-month follow-up of naltrexone and psychotherapy for alcohol dependence","volume":"53","author":"O'Malley","year":"1996","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib231","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence: a controlled study","volume":"49","author":"O'Malley","year":"1992","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib232","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004714-200002000-00012","article-title":"Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects","volume":"20","author":"O'Malley","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib233","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1530-0277.2008.00698.x","article-title":"A placebo\u2010controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention","volume":"32","author":"Oslin","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib234","first-page":"401","article-title":"Endogenous neuropeptide nocistatin is a direct agonist of acid-sensing ion channels (ASIC1, ASIC2 and ASIC3)","volume":"9","author":"Osmakov","year":"2019","journal-title":"Biomol"},{"key":"10.1016\/j.neuropharm.2022.109376_bib235","article-title":"Atypical opioid receptors: unconventional biology and therapeutic opportunities","volume":"233","author":"Palmer","year":"2021","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109376_bib236","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2018.12.034","article-title":"The etiology of DSM-5 alcohol use disorder: evidence of shared and non-shared additive genetic effects","volume":"201","author":"Palmer","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2022.109376_bib237","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cell.2019.06.034","article-title":"A paranigral VTA nociceptin circuit that constrains motivation for reward","volume":"178","author":"Parker","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109376_bib238","doi-asserted-by":"crossref","DOI":"10.1124\/mol.120.119438","article-title":"Pain, motivation, migraine and the microbiome: new frontiers for opioid systems and disease","volume":"98","author":"Parker","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib239","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109376_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100149","article-title":"Sex differences in stress-related alcohol use","volume":"10","author":"Peltier","year":"2019","journal-title":"Neurobiology Stress"},{"key":"10.1016\/j.neuropharm.2022.109376_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172808","article-title":"Peripheral antinociception induced by ketamine is mediated by the endogenous opioid system","volume":"865","author":"Petrocchi","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib242","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1530-0277.2011.01524.x","article-title":"Efficacy of extended\u2010release naltrexone in patients with relatively higher severity of alcohol dependence","volume":"35","author":"Pettinati","year":"2011","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110616","article-title":"An atlas of transcriptionally defined cell populations in the rat ventral tegmental area","volume":"39","author":"Phillips","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2022.109376_bib244","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-8993(93)90693-H","article-title":"Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra","volume":"602","author":"Pickel","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib245","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/syn.890190303","article-title":"Neuropeptide Y and dynorphin\u2010immunoreactive large dense\u2010core vesicles are strategically localized for presynaptic modulation in the hippocampal formation and substantia nigra","volume":"19","author":"Pickel","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2022.109376_bib246","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/cne.901890408","article-title":"Immunocytochemical localization of enkephalin in the neostriatum of rat brain: a light and electron microscopic study","volume":"189","author":"Pickel","year":"1980","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib247","doi-asserted-by":"crossref","first-page":"14567","DOI":"10.1523\/JNEUROSCI.0649-13.2013","article-title":"Delta-opioid receptors mediate unique plasticity onto parvalbumin-expressing interneurons in area CA2 of the Hippocampus","volume":"33","author":"Piskorowski","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib248","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41386-020-0738-4","article-title":"Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the fast-fail trial in mood and anxiety spectrum disorders (FAST-MAS)","volume":"45","author":"Pizzagalli","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib249","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1523\/JNEUROSCI.2317-18.2019","article-title":"Synaptic regulation by OPRM1 variants in reward neurocircuitry","volume":"39","author":"Popova","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0165-6147(89)90267-8","article-title":"Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists","volume":"10","author":"Portoghese","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib251","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cne.21587","article-title":"Enkephalin co\u2010expression with classic neurotransmitters in the amygdaloid complex of the rat","volume":"506","author":"Poulin","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib252","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.pnpbp.2009.06.021","article-title":"Neuroanatomical characterization of endogenous opioids in the bed nucleus of the stria terminalis","volume":"33","author":"Poulin","year":"2009","journal-title":"Prog Neuro-psychopharmacology Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109376_bib253","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41593-018-0203-4","article-title":"Mapping projections of molecularly defined dopamine neuron subtypes using intersectional genetic approaches","volume":"21","author":"Poulin","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib254","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tips.2011.06.008","article-title":"The delta opioid receptor: an evolving target for the treatment of brain disorders","volume":"32","author":"Pradhan","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib255","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1523\/JNEUROSCI.4146-10.2011","article-title":"A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia","volume":"31","author":"Psifogeorgou","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib256","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1023\/A:1012185919153","article-title":"Dynorphin peptides: antagonists of melanocortin receptors","volume":"14","author":"Quillan","year":"1997","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib257","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/carcin\/23.11.1911","article-title":"Cellular background level of 8-oxo-7,8-dihydro-2\u2032-deoxyguanosine: an isotope based method to evaluate artefactual oxidation of DNA during its extraction and subsequent work-up","volume":"23","author":"Ravanat","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neuropharm.2022.109376_bib258","first-page":"289","article-title":"Five-year follow-up of opiate addicts with naltrexone and behavior therapy","volume":"49","author":"Rawson","year":"1984","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib259","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.64.9.1069","article-title":"Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study","volume":"64","author":"Ray","year":"2007","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib260","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8279","article-title":"Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders","volume":"3","author":"Ray","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neuropharm.2022.109376_bib261","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0006-8993(86)90821-8","article-title":"The co-occurrence of substance P-like immunoreactivity and dynorphin-like immunoreactivity in striatopallidal and striatonigral projection neurons in birds and reptiles","volume":"371","author":"Reiner","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib262","doi-asserted-by":"crossref","first-page":"14163","DOI":"10.1074\/jbc.271.24.14163","article-title":"Structure-activity relationship studies on the novel neuropeptide orphanin FQ","volume":"271","author":"Reinscheid","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib263","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.270.5237.792","article-title":"Orphanin fq: a neuropeptide that activates an opioidlike G protein-coupled receptor","volume":"270","author":"Reinscheid","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109376_bib264","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1460-9568.2006.04744.x","article-title":"Pro\u2010opiomelanocortin colocalizes with corticotropin\u2010 releasing factor in axon terminals of the noradrenergic nucleus locus coeruleus","volume":"23","author":"Reyes","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib265","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00329443","article-title":"Two different types of dynorphin-A-immunoreactive terminals in rat substantia nigra","volume":"261","author":"Riesenberg","year":"1990","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib266","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/npp.2015.109","article-title":"Receptor reserve moderates mesolimbic responses to opioids in a humanized mouse model of the OPRM1 A118G polymorphism","volume":"40","author":"Robinson","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108362","article-title":"Prepronociceptin-expressing neurons in the extended amygdala encode and promote rapid arousal responses to motivationally salient stimuli","volume":"33","author":"Rodriguez-Romaguera","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2022.109376_bib268","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00023210-200418090-00001","article-title":"What place does naltrexone have in the treatment of alcoholism?","volume":"18","author":"Rohsenow","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2022.109376_bib269","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2021.686279","article-title":"Cellular diversity and differential subcellular localization of the G-protein G\u03b1o subunit in the mouse cerebellum","volume":"15","author":"Rold\u00e1n-Sastre","year":"2021","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuropharm.2022.109376_bib270","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0006-291X(79)91200-2","article-title":"Tetrapeptide-amide analogues of enkephalin: the role of C-terminus in determining the character of opioid activity","volume":"91","author":"R\u00f3nai","year":"1979","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.neuropharm.2022.109376_bib271","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/acer.13052","article-title":"A novel, orally bioavailable nociceptin receptor antagonist, LY2940094, reduces ethanol self\u2010administration and ethanol seeking in animal models","volume":"40","author":"Rorick-Kehn","year":"2016","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib272","doi-asserted-by":"crossref","first-page":"pyv127","DOI":"10.1093\/ijnp\/pyv127","article-title":"Supersensitive kappa opioid receptors promotes ethanol withdrawal-related behaviors and reduce dopamine signaling in the nucleus accumbens","volume":"19","author":"Rose","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib273","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1124\/jpet.300.1.257","article-title":"Characterization of rat prepro-orphanin FQ\/Nociceptin(154\u2013181): nociceptive processing in supraspinal sites","volume":"300","author":"Rossi","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109376_bib274","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0006-2952(03)00391-5","article-title":"Degradation of endomorphin-2 at the supraspinal level in mice is initiated by dipeptidyl peptidase IV: an in vitro and in vivo study","volume":"66","author":"Sakurada","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib275","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0196-9781(97)00025-9","article-title":"Differential metabolism of dynorphins in substantia nigra, striatum, and Hippocampus","volume":"18","author":"Sandin","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2022.109376_bib276","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jpain.2020.01.001","article-title":"Dynorphin and enkephalin opioid peptides and transcripts in spinal cord and dorsal root ganglion during peripheral inflammatory hyperalgesia and allodynia","volume":"21","author":"Sapio","year":"2020","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2022.109376_bib277","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.bmc.2005.11.021","article-title":"ORL1 and opioid receptor preferences of nociceptin and dynorphin A analogues with Dmp substituted for N-terminal aromatic residues","volume":"14","author":"Sasaki","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib278","doi-asserted-by":"crossref","first-page":"12004","DOI":"10.1073\/pnas.95.20.12004","article-title":"Target cell-specific modulation of transmitter release at terminals from a single axon","volume":"95","author":"Scanziani","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109376_bib279","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/acer.14440","article-title":"A call to action: a systematic review examining the failure to include females and members of minoritized racial\/ethnic groups in clinical trials of pharmacological treatments for alcohol use disorder","volume":"44","author":"Schick","year":"2020","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2011.07.013","article-title":"Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL\/6J and 129P3\/J mice: strain and heroin effects","volume":"100","author":"Schlussman","year":"2011","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109376_bib281","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ceca.2012.04.011","article-title":"Ca2+ channels and transmitter release at the active zone","volume":"52","author":"Schneggenburger","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuropharm.2022.109376_bib282","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/01.ALC.0000141814.80716.32","article-title":"Findings across subgroups regarding the level of response to alcohol as a risk factor for alcohol use disorders: a college population of women and latinos","volume":"28","author":"Schuckit","year":"2004","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib283","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/01.alc.0000187154.94681.65","article-title":"A cross-generational comparison of alcohol challenges at about age 20 in 40 father-offspring pairs","volume":"29","author":"Schuckit","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib284","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.1977.tb41843.x","article-title":"ACTH: a short introductory review","volume":"297","author":"Schwyzer","year":"1977","journal-title":"Ann Ny Acad Sci"},{"key":"10.1016\/j.neuropharm.2022.109376_bib285","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1523\/JNEUROSCI.12-04-01335.1992","article-title":"Dual ultrastructural localization of enkephalin and tyrosine hydroxylase immunoreactivity in the rat ventral tegmental area: multiple substrates for opiate-dopamine interactions","volume":"12","author":"Sesack","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib286","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(94)01391-T","article-title":"Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area","volume":"672","author":"Sesack","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib287","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0006-8993(98)01121-4","article-title":"Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV","volume":"815","author":"Shane","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib288","doi-asserted-by":"crossref","first-page":"14371","DOI":"10.1523\/JNEUROSCI.2186-09.2009","article-title":"Dynorphin opioid peptides enhance acid-sensing ion channel 1a activity and acidosis-induced neuronal death","volume":"29","author":"Sherwood","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib289","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.neuron.2019.03.031","article-title":"Synaptic vesicle recycling pathway determines neurotransmitter content and release properties","volume":"102","author":"Silm","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109376_bib290","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0896-6273(95)90273-2","article-title":"L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells","volume":"14","author":"Simmons","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109376_bib291","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.neuropharm.2022.109376_bib292","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/aja.1001540212","article-title":"Immunoreactive \u03b2\u2010endorphin and acth in the same neurons of the hypothalamic arcuate nucleus in the rat","volume":"154","author":"Sofroniew","year":"1979","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.neuropharm.2022.109376_bib293","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.kjms.2011.06.011","article-title":"Dorsal hippocampal N\u2010methyl\u2010d\u2010aspartate glutamatergic and \u03b4\u2010opioidergic systems modulate anxiety behaviors in rats in a noninteractive manner","volume":"27","author":"Solati","year":"2011","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib294","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1440-1819.2010.02143.x","article-title":"Dorsal hippocampal opioidergic system modulates anxiety\u2010like behaviors in adult male Wistar rats","volume":"64","author":"Solati","year":"2010","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2008.12.002","article-title":"Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration","volume":"1255","author":"Solecki","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib296","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-010-1844-5","article-title":"Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration","volume":"210","author":"Sperling","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib297","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2741\/3306","article-title":"The evolution of vertebrate opioid receptors","volume":"ume","author":"Stevens","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib298","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1111\/j.1530-0277.1998.tb05932.x","article-title":"Effects of naltrexone administered repeatedly across 30 or 60 Days on ethanol consumption using a limited access procedure in the rat","volume":"22","author":"Stromberg","year":"1998","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib299","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/cne.903530410","article-title":"Opioid precursor gene expression in the human hypothalamus","volume":"353","author":"Sukhov","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib300","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1529\/biophysj.104.048538","article-title":"Rapid hop diffusion of a G-protein-coupled receptor in the plasma membrane as revealed by single-molecule techniques","volume":"88","author":"Suzuki","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2022.109376_bib301","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nmeth.4220","article-title":"Power analysis of single-cell RNA-sequencing experiments","volume":"14","author":"Svensson","year":"2017","journal-title":"Nat. Methods"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2022.109376_bib302","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(84)90374-1","article-title":"Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists","volume":"104","author":"Takemori","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib303","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nmeth.1315","article-title":"mRNA-Seq whole-transcriptome analysis of a single cell","volume":"6","author":"Tang","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2022.109376_bib304","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0006-8993(02)03180-3","article-title":"Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-d-aspartate receptor mechanism","volume":"952","author":"Tan-No","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib305","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.lfs.2007.09.025","article-title":"Search of the human proteome for endomorphin-1 and endomorphin-2 precursor proteins","volume":"81","author":"Terskiy","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib306","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bcp.2016.05.014","article-title":"Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor","volume":"113","author":"Thompson","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib307","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/mol.115.098848","article-title":"Biased agonism of endogenous opioid peptides at the \u03bc-opioid receptor","volume":"88","author":"Thompson","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib308","doi-asserted-by":"crossref","first-page":"9263","DOI":"10.1074\/jbc.M113.505685","article-title":"A two-state model for the diffusion of the A2A adenosine receptor in hippocampal neurons AGONIST-INDUCED SWITCH TO SLOW MOBILITY IS MODIFIED BY SYNAPSE-ASSOCIATED PROTEIN 102 (SAP102)*","volume":"289","author":"Thurner","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib309","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109376_bib310","series-title":"Incorporating Alcohol Pharmacotherapies into Medical Practice","year":"2009"},{"key":"10.1016\/j.neuropharm.2022.109376_bib311","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1126\/science.abl5130","article-title":"Angiotensin-converting enzyme gates brain circuit\u2013specific plasticity via an endogenous opioid","volume":"375","author":"Trieu","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109376_bib312","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1017\/S0033291714002165","article-title":"The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies","volume":"45","author":"Verhulst","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2022.109376_bib313","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2022.102167","article-title":"Organisation of enkephalin inputs and outputs of the central nucleus of the amygdala in mice","volume":"125","author":"Viden","year":"2022","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2022.109376_bib314","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(82)90477-0","article-title":"Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway","volume":"85","author":"Vincent","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib315","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0026-895X(25)13810-8","article-title":"Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines","volume":"16","author":"Viveros","year":"1979","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib316","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib317","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.1997.01830200071010","article-title":"Naltrexone and alcohol dependence: role of subject compliance","volume":"54","author":"Volpicelli","year":"1997","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109376_bib318","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1159\/000126428","article-title":"Effects of single and repeated exposures to ethanol on hypothalamic \u03b2-endorphin and CRH release by the C57bl\/6 and DBA\/2 strains of mice","volume":"57","author":"de Waele","year":"1993","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib319","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0014-2999(85)90608-9","article-title":"In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain","volume":"117","author":"Waksman","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib320","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41593-018-0275-1","article-title":"Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders","volume":"21","author":"Walters","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib321","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fncel.2014.00455","article-title":"Presynaptic nanodomains: a tale of two synapses","volume":"8","author":"Wang","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib322","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/syn.10008","article-title":"Immunoelectron microscopic study of \u03b2\u2010endorphinergic synaptic innervation of GABAergic neurons in the dorsal raphe nucleus","volume":"42","author":"Wang","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2022.109376_bib323","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0006-8993(03)02290-X","article-title":"Electron microscopic examination of the endomorphin 2-like immunoreactive neurons in the rat hypothalamus","volume":"969","author":"Wang","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib324","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1152\/jn.1996.76.5.3568","article-title":"Nociceptin (orphanin FQ), an endogenous ligand for the QRL1 (opioid-receptor-like1) receptor; modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli","volume":"76","author":"Wang","year":"1996","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib325","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1021\/jm300664y","article-title":"A new class of highly potent and selective endomorphin-1 analogues containing \u03b1-Methylene-\u03b2-aminopropanoic acids (map)","volume":"55","author":"Wang","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib326","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.6121376","article-title":"Dynorphin and vasopressin: common localization in magnocellular neurons","volume":"216","author":"Watson","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109376_bib327","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/1096-9861(20000828)424:3<439::AID-CNE4>3.0.CO;2-1","article-title":"Regional and cellular localization of the neuroendocrine prohormone convertases PC1 and PC2 in the rat central nervous system","volume":"424","author":"Winsky-Sommerer","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib328","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14611","article-title":"Endogenous opioids regulate moment-to-moment neuronal communication and excitability","volume":"8","author":"Winters","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109376_bib329","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pharmthera.2013.10.011","article-title":"The biology of Nociceptin\/Orphanin FQ (N\/OFQ) related to obesity, stress, anxiety, mood, and drug dependence","volume":"141","author":"Witkin","year":"2014","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109376_bib330","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/164_2018_186","article-title":"The nociceptin\/orphanin FQ peptide receptor","volume":"254","author":"Witkin","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib331","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1213\/ane.0b013e31817300be","article-title":"The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies","volume":"106","author":"Xie","year":"2008","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2022.109376_bib332","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1096\/fj.06-6174fje","article-title":"Prodynorphin storage and processing in axon terminals and dendrites","volume":"20","author":"Yakovleva","year":"2006","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2022.109376_bib333","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aao1917","article-title":"Single-molecule diffusion-based estimation of ligand effects on G protein\u2013coupled receptors","volume":"11","author":"Yanagawa","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2022.109376_bib334","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(89)90539-6","article-title":"Chronic opioid antagonist treatment: assessment of receptor upregulation","volume":"170","author":"Yoburn","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib335","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WNF.0000000000000152","article-title":"High-dose naltrexone treatment and gender in alcohol dependence","volume":"39","author":"Yoon","year":"2016","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib336","doi-asserted-by":"crossref","first-page":"14301","DOI":"10.1016\/S0021-9258(18)89893-3","article-title":"Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system","volume":"259","author":"Yoshikawa","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib337","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/cmdc.200600274","article-title":"Structure\u2013activity study on the spatial arrangement of the third aromatic ring of endomorphins 1 and 2 using an atypical constrained C terminus","volume":"2","author":"Yu","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.neuropharm.2022.109376_bib338","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the \u03bc-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109376_bib339","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuropharm.2015.12.024","article-title":"Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine","volume":"105","author":"Zadina","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109376_bib340","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.peptides.2004.11.010","article-title":"Deficit in beta-endorphin peptide and tendency to alcohol abuse","volume":"26","author":"Zalewska-Kaszubska","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2022.109376_bib341","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-8993(97)00858-5","article-title":"Orphanin FQ has an inhibitory effect on the Guinea pig ileum and the mouse vas deferens","volume":"772","author":"Zhang","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109376_bib342","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nn.3945","article-title":"Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons","volume":"18","author":"Zhang","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109376_bib343","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1021\/acs.jcim.7b00717","article-title":"Dissecting the innate immune recognition of opioid inactive isomer (+)-Naltrexone derived toll-like receptor 4 (TLR4) antagonists","volume":"58","author":"Zhang","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.neuropharm.2022.109376_bib344","doi-asserted-by":"crossref","first-page":"32618","DOI":"10.1074\/jbc.M504942200","article-title":"Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G","volume":"280","author":"Zhang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109376_bib345","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bjp.0704806","article-title":"Actions of orphanin FQ\/nociceptin on rat ventral tegmental area neurons in vitro","volume":"136","author":"Zheng","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109376_bib346","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0306-4522(86)90004-7","article-title":"Exocytosis from large dense cored vesicles outside the active synaptic zones of terminals within the trigeminal subnucleus caudalis: a possible mechanism for neuropeptide release","volume":"19","author":"Zhu","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109376_bib347","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0006-8993(82)90811-3","article-title":"Naltrexone-induced opiate receptor supersensitivity","volume":"245","author":"Zukin","year":"1982","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082200435X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082200435X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:25:17Z","timestamp":1758439517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082200435X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":347,"alternative-id":["S002839082200435X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109376","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109376"}}